PA
TDOC icon

Procyon Advisors’s Teladoc Health TDOC Stock Holding History

Procyon Advisors’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-8
Closed -$2K – 959
2020
Q2 		$2K Sell
8
-84
-91% -$14.7K ﹤0.01% 946
2020
Q1 		$14K Sell
92
-117
-56% -$13.6K 0.01% 542
2019
Q4 		$17K Buy
+209
New +$15.9K 0.01% 530

Other funds holding TDOC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DVF
Discovery Value Fund Singapore $39.8M AUM 27.89% 1-Year Est. Return

Procyon Advisors's TDOC Position: Q3 2020 in Review

Procyon Advisors sold out of Teladoc Health (TDOC) in Q3 2020, closing a stake of 8 shares — an estimated $2K sold.

Procyon Advisors first reported a position in TDOC in Q4 2019 and held it in 3 quarters. The position peaked at $17K in Q4 2019. 743 funds tracked by Wall St. Rank hold TDOC as of Q3 2020.

  • Procyon Advisors reported no remaining Teladoc Health position as of Q3 2020 after selling out during the quarter.
  • Procyon Advisors sold 8 Teladoc Health shares in Q3 2020, an estimated $2K.
  • Procyon Advisors first reported a position in Teladoc Health in Q4 2019 and held it in 3 quarters.
  • Procyon Advisors's Teladoc Health position peaked at $17K in Q4 2019.
  • 743 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2020.

Based on Procyon Advisors's 13F filing for Q3 2020, filed 22 Oct 2020.